secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marker Therapeutics, Inc. (MRKR)
CIK:        0001094038
Form:       8-K
Filed at:   2024-06-12T23:59:59+00:00
Accession:  0001104659-24-070830
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Marker Therapeutics terminates ATM equity facility; shareholders elect board, approve auditor and pay
--------------------------------------------------------------------------------

- Shareholders elected five directors: D. Eansor, S. Elms, J. Wilson, J. Vera, K. Knobil; each with >3M votes for.
- Advisory 'say-on-pay' vote passed 2,931,920 for vs 276,480 against, with 14,000 abstentions.
- Ratification of Marcum LLP as auditor for FY2024 passed 5,137,819 for vs 494,128 against, with 14,366 abstentions.
- Terminated ATM equity facility with Cantor Fitzgerald & Co. and RBC Capital Markets; facility allowed up to $75M in stock sales, no termination penalties.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1094038/000110465924070830/0001104659-24-070830-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1094038/000110465924070830/tm2416968d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-070830

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer